Next Article in Journal
Anti-Inflammatory Polyketides from an Alga-Derived Fungus Aspergillus ochraceopetaliformis SCSIO 41020
Previous Article in Journal
Extraction and Identification of Three New Urechis unicinctus Visceral Peptides and Their Antioxidant Activity
Previous Article in Special Issue
Evaluation of a Thermophilic, Psychrostable, and Heavy Metal-Resistant Red Sea Brine Pool Esterase
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Genome Mining of α-Pyrone Natural Products from Ascidian-Derived Fungus Amphichordafelina SYSU-MS7908

1
School of Maine Sciences, Sun Yat-sen University, Guangzhou 510006, China
2
Southern Laboratory of Ocean Science and Engineering (Guangdong, Zhuhai), Zhuhai 519000, China
3
Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Zhuhai 519000, China
4
Pearl River Estuary Marine Ecosystem Research Station, Ministry of Education, Zhuhai 519082, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Mar. Drugs 2022, 20(5), 294; https://doi.org/10.3390/md20050294
Submission received: 20 March 2022 / Revised: 24 April 2022 / Accepted: 26 April 2022 / Published: 27 April 2022

Abstract

:
Culturing ascidian-derived fungus Amphichorda felina SYSU-MS7908 under standard laboratory conditions mainly yielded meroterpenoid, and nonribosomal peptide-type natural products. We sequenced the genome of Amphichorda felina SYSU-MS7908 and found 56 biosynthetic gene clusters (BGCs) after bioinformatics analysis, suggesting that the majority of those BGCSs are silent. Here we report our genome mining effort on one cryptic BGC by heterologous expression in Aspergillus oryzae NSAR1, and the identification of two new α-pyrone derivatives, amphichopyrone A (1) and B (2), along with a known compound, udagawanone A (3). Anti-inflammatory activities were performed, and amphichopyrone A (1) and B (2) displayed potent anti-inflammatory activity by inhibiting nitric oxide (NO) production in RAW264.7 cells with IC50 values 18.09 ± 4.83 and 7.18 ± 0.93 μM, respectively.

Graphical Abstract

1. Introduction

Fungal natural products are an indispensable source for drug development [1,2]. However, under typical laboratory culture conditions, most of the biosynthetic gene clusters (BGCs) from fungi are “silent”; thus, it becomes increasingly difficult to discover novel natural products. Currently, several genome mining strategies have been reported for activating silent BGCs [3], and heterologous expression of target BGCs in a suitable host is one effective approach. Zhu et al. [4] expressed a cryptic BGC from Trichoderma harzianum t-22 in Aspergillus nidulans A1145 and successfully isolated several tetronate natural products, such as trihazone A–F. Similarly, Li et al. [5] characterized a cryptic BGC from A. hancockii in A. nidulans LO8030 and discovered a metabolite with a unique prenylated 6/6/6/5 tetracarbocyclic skeleton. The quadruple auxotroph A. oryzae NSAR1 is also a frequently-used heterologous host for genome mining of fungal natural products. Recently, Jiang et al. [6] used A. oryzae as a heterologous host to express two fungal bifunctional terpene synthases and obtained four terpenes featuring 5-6-7-3-5 ring systems; Yan et al. [7] genome mined four new meroterpenoids, funiculolides A−D, by heterologous expression of a cryptic BGC from A. funiculosus CBS 116.56.
Discovering novel secondary metabolites from marine-derived fungi has been our group’s long-term research interest [8,9,10,11]. The fungus Amphichorda felina SYSU-MS7908 was isolated from a marine ascidian Styelaplicata and fermentation under standard laboratory conditions mainly gave meroterpenoids and nonribosomal peptides [12,13]. To probe the biosynthetic potential of A. felina SYSU-MS7908, the genome was sequenced by Illumina second-generation sequencing, and the assembled genome was analyzed by the antibiotics and secondary metabolite analysis shell (antiSMASH) [14]. Fifty-six secondary metabolites BGCs were found (Figure S1), suggesting that the fungus has great potential to produce structurally diverse natural products.
Pyrones are six-membered cyclic unsaturated esters exhibiting a broad range of activities, such as antifungal, antibiotic, cytotoxic, immunosuppressive, and phytotoxic (Figure 1) [15,16,17]. One gene cluster, the amp cluster discovered from A. felina SYSU-MS7908, shares similarities with the sol cluster that is responsible for the biosynthesis of solanapyrone D (Figure 2), an α-pyrone containing natural product [18]. However, we had not observed the production of such metabolites from the wild type of A. felina SYSU-MS7908, suggesting that this BGC might be silent. We decided to activate this BGC by heterologous expression in A. oryzae NSAR1 as it is a robust host to mine fungal natural products [19,20,21].

2. Results and Discussion

2.1. Bioinformatic Analysis of the Amp Cluster

The amp cluster contains 10 potential biosynthetic genes (transcription factor and transport excluded, Table 1). AmpB is a polyketide synthase (PKS) that shares 52% protein identity with Sol1 (Figure S2), the PKS involved in solanapyrone D biosynthesis [18,23,24]. AmpC, a putative methyltransferase, shares 49.5% protein identity with Sol2 (Figure S3). Interestingly, no other genes share significant sequence homology between those two clusters (Figure 2), suggesting that the amp cluster might produce structurally divergent natural products from solanapyrone D.

2.2. Heterologous Expression of the Amp Cluster in A. oryzae

Previous studies suggested that the PKS, Sol1, could produce an advanced biosynthetic intermediate; thus, only the ampB gene was introduced into the A. oryzae NSAR1 host strain. As expected, the production of amphichopyrone A (1) was detected from the expression of the AO-ampB construct (Figure 3). With amphichopyrone A (1) determined, we next focused on the tailoring genes of the amp cluster. AmpC, a putative O-methyltransferase, was then introduced into AO-ampB to give the construct AO-ampBC. We found that two additional metabolites were produced by AO-ampBC. Large-scale fermentation and spectroscopic analyses determined the structures as amphichopyrone B (2) and udagawanone A (3) [15,16,17].
To investigate the final metabolites produced by the amp cluster, the remaining eight genes, ampADEFGHIJ, were included in the construct; unfortunately, the AO-ampABCDEFGHIJ construct generated the same product profile as AO-ampBC (Figure 3), suggesting amphichopyrone (2) and udagawanone A (3) might be the final products catalyzed by the amp cluster (Figure 4). These results suggest that AmpC catalyzed the methylation reaction at C-4 hydroxyl of amphichopyrone A (1) to give amphichopyrone B (2). Hydroxylation of amphichopyrone B (2) to udagawanone A (3) might be catalyzed by endogenous enzymes from A. oryzae NSAR1 host (Figure 5).

2.3. Characterization of amphichopyrone A (1) and B (2)

Amphichopyrone A (1) was obtained as a white solid. The positive HR-ESI-MS gave an m/z 181.0860 [M+H]+, consistent with the molecular formula C10H13O3 with five degrees of unsaturation (Figure S4). The IR absorption spectrum suggested the presence of hydroxyl (3545 cm−1), conjugated carboxyl ester (1668 cm−1), and olefinic (1568 cm−1) functional groups in the molecule (Figure S5). The UV maxima at approximately 222 and 325 nm suggested the presence of an α-pyrone substructure (Figure S6) [17,25,26]. The 1H NMR, DEPT NMR, and HSQC experiments showed two olefinic proton signals [δH 6.42 (1H, dq, J = 15.4, 1.3 Hz)/δC 120.6 and 6.50 (1H, dq, J = 15.4, 6.0 Hz)/δC 132.0] and three methyls [δH 1.90 (3H, d, J = 6.0 Hz)/δC 17.6; δH 1.94 (3H, s)/δC 8.6 and δH 2.01 (3H, s)/δC 8.5] (Table 2). Except for the above-mentioned five carbons, the 13C NMR spectrum and HSQC experiment revealed the presence of five non-protonated carbons, which were attributed to the 3,4,5,6-tetrasubstituted α-pyrone skeleton (δC 99.0, 106.3, 151.6, 163.6, 164.3), consisting of one carbonyl carbon and four sp2 carbons. The HMBC correlations of CH3-10 to C-2 (δC 163.6), C-3 (δC 99.0) and C-4 (δC 164.3), CH3-11 to C-4 (δC 164.3), C-5 (δC 106.3) and C-6 (δC 151.6), and CH3-9 to C-6 (δC 151.6), C-7 (δC 120.6) and C-8 (δC 132.0), which suggested the presence of methyl at C-3 and C-5 site in α-pyrone, and the connection of C-6 site in α-pyrone to the propenyl chain (Figure 6). The coupling constant (15.4 Hz) of two olefinic protons established the trans geometric configuration for ∆7(8). Hence, the structure of compound 1 was elucidated as (E)-4-hydroxy-3,5-dimethyl-6-(prop-1-en-1-yl)-2H-pyran-2-one and named amphichopyrone A (1).
Amphichopyrone B (2) was obtained as a white solid. The molecular formula was determined as C11H15O3 based on the positive HR-ESIMS ions at m/z 195.1019 [M+H]+ (calcd. for 195.1016, C11H15O3), suggesting five degrees of unsaturation (Figure S7). The IR absorption bands at 3394, 1668, and 1568 cm−1, indicated the presence of hydroxyl, conjugated carboxyl ester, and olefinic groups in the molecule (Figure S8). Its UV spectrum (λmax 227 and 332 nm) was indicative of the presence of α-pyrone substructure (Figure S9) [18,25,26]. The NMR and HSQC experiments showed two olefinic proton signals [δH 6.42 (1H, dq, J = 15.4 1.3 Hz)/δC 121.4 and 6.51 (1H, dq, J = 15.4, 6.5 Hz)/δC 133.1] and four methyls [δH 1.91 (3H, d, J = 6.5 Hz)/δC 18.6; δH 1.96 (3H, s)/δC 10.4; δH 1.98 (3H, s)/δC 9.5 and δH 3.83 (3H, s)/δC 60.7] (Table 2). Except for the above-mentioned six carbons, the 13C NMR spectrum and HSQC experiment revealed the presence of five non-protonated carbons, which were attributed to the 3,4,5,6-tetrasubstituted α-pyrone skeleton (δC 109.4, 111.2, 153.0, 164.5, 168.7), consisting of one carbonyl carbon and four sp2 carbons. The HMBC correlations of CH3-10 to C-2 (δC 164.5), C-3 (δC 111.2) and C-4 (δC 168.7), CH3-11 to C-4 (δC 168.7), C-5 (δC 109.4) and C-6 (δC 153.0), OCH3-12 to C-4 (δC 168.7) and CH3-9 to C-6 (δC 153.0), C-7 (δC 121.4) and C-8 (δC 133.1), which suggested the presence of methyl at C-3 and C-5 site, methoxy at C-4 site in α-pyrone, and the connection of C-6 site in α-pyrone to the propenyl chain (Figure 6). The coupling constant (15.4 Hz) of two olefinic protons established the trans geometric configuration for ∆7(8). Hence, the structure of compound 2 was elucidated as (E)-4-methoxy-3,5-dimethyl-6-(prop-1-en-1-yl)-2H-pyran-2-one and named amphichopyrone B (2).

2.4. Evaluation of Anti-Inflammatory Activity

Compounds 13 were evaluated for in vitro anti-inflammatory activity. Amphichopyrone A (1) and B (2) displayed potent anti-inflammatory activity by inhibiting LPS-induced NO production with IC50 values 18.09 ± 4.83 and 7.18 ± 0.93 μM, respectively. Interestingly, udagawanone A (3) shows no activity up to 50 μM, suggesting the C-10 hydroxyl group is detrimental for its anti-inflammatory activity. The pro-inflammatory enzymes, inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and transcriptional regulators, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β), have been shown to play key roles in inflammatory processes [27,28]. Thus, qPCR experiments were conducted to detect the effect of amphichopyrone B on the activated iNOS, COX-2, TNF-α, IL-6, and IL-1β. The results showed that the mRNA expression levels of iNOS, COX-2, TNF-α, IL-6, and IL-1β were down-regulated with the increased concentration of amphichopyrone B (Figure 7), indicating that LPS-induced inflammatory process was inhibited by amphichopyrone B.

3. Materials and Methods

3.1. General Materials

Chemicals were purchased from Sangon Biotech Co., Ltd. (Shanghai, China), Thermo Fisher Scientific (Shanghai, China), Sigma-Aldrich Trading Co., Ltd. (Shanghai, China) or J&K Scientific Ltd (Beijing, China). unless noted otherwise. Column Chromatography (CC) was carried out using silica gel (200–300 mesh, Qingdao Marine Chemical Factory, Qingdao, China).
DNA Sequence analysis and primer synthesis were performed by TsingKe Biological Technology Co., Ltd. (Guangzhou, China). Plasmid extraction kits and DNA purification kits were purchased from Tianjin Biotech Co., Ltd. (Beijing, China). PCR analysis was accomplished using a Bio-Rad CFX™ Thermal Cycle with Phanta Super-Fidelity DNA Polymerase (Vazyme, Nanjing, China). The assembly of DNA fragments and the construction of recombinant plasmids were performed by using Clone Express® MultiS One Step Cloning Kit (Vazyme, Nanjing, China). Yatalase™ was purchased from Takara Co., Ltd. (Dalian, China). UV spectra were collected on Waters 2998 photodiode array detector (Waters, Boston, MA, USA). NMR spectra were obtained on a Bruker Avance 400 MHz (Bruker, Switzerland) with tetramethylsilane (TMS) as the internal standard. HR-ESIMS data were measured on a Thermos LCQ DECA XP plus mass spectrometer using a Luna 5u C18 (2) 100A 150×4.60 mm 5-micron column (Thermos Scientific, Waltham, MA, USA). The Semi-preparative and analytical HPLC were performed on a Waters 1525 system equipped with a Waters 2998 photodiode array detector (Waters, Boston, MA, USA), using a Welch Ultimate® XB-C18 column (10 mm × 250 mm, 5 μm, Welch Materials, Inc., Shanghai, China) and COSMOSIL 5C18-AR-II column (4.6 mm × 250 mm, 5 μm, NacalaiTesque, Inc., Kyoto, Japan), respectively. The mobile phases for analytical HPLC were H2O containing 0.1% formic acid (A) and CH3CN containing 0.1% formic acid (B), and the gradient elution was 15–80% B (0–15 min), 80–100% B (15–20 min), 100–100% B (20–28 min), 100–15% B (28–30 min), and 15% B (30–33 min) with a flow rate of 1 mL/min.

3.2. Strains and Media

The strain, Amphichorda felina SYSU-MS7908, was isolated from a marine ascidian Styelaplicata collected from the north atoll of the Xisha Islands, South China Sea, China, in 2018, isolated using the standard protocol [29] and identified by the morphological and the internal transcribed spacer (ITS) of the nuclear ribosomal DNA data analysis (Accession number MT786206). The whole genome sequences of A. felina SYSU-MS7908 have been deposited in the GenBank database with an accession number JAEMHR000000000. The sequences of amp A-J have been submitted to GenBank (OL906410-OL906419). The proposed functions of ampA-J in Table 1 are based on the protein BLAST results. The gene cluster comparison figure between the amp and sol clusters was generated with the Clinker tools with the corresponding annotated sequence files using default parameters [22]. Primer sequences are listed in Table S1.
The heterologous expression host Aspergillus oryzae NSAR1 and corresponding plasmids were gifts from professors Ikuro Abe and Katsuhiko Kitamoto (the University of Tokyo, Tokyo, Japan) [30]. The mycelia of A. oryzae strains expressing the respective constructs were inoculated into 10 mL DPY medium (2% dextrin, 1% polypeptide, 0.5% yeast extract, 0.5% KH2PO4, 0.05% MgSO4.7H2O) and cultured at 28 °C and 220 rpm for 2 days. Then the DPY medium was transferred to the 100 mL modified Czapek-Dox (CD) medium (0.3% NaNO3, 0.2% KCl, 0.05% MgSO4.7H2O, 0.1% KH2PO4, 0.002% FeSO4.7H2O, 1% polypeptide, 2% starch, pH 5.5), and grown at 28 °C and 220 rpm for 6 days to induce the expression of heterologous genes under the amyB promoter.

3.3. Construction of Recombinant Plasmids

To construct the expression plasmids for A. oryzae, the genes (ampA-ampJ) of the amp cluster were first amplified using the genomic DNA of Amphichorda felina SYSU-MS7908 as a template. Each amplified DNA fragment was then introduced into the pTAex3 vector [31], and the gene expression cassette, amyB promoter, the target gene, and the amyB terminator were amplified from the pTAex3-based plasmid. These gene expression cassettes were then inserted into the HindIII-linearlized pPTRI [32], pBARI [33], SpeI-linearized pAdeA [34], and XbaI-linearized pUNA [35]. Plasmids constructed in this study are listed in Table S2.

3.4. Transformation of A. oryzae NSAR1

The transformation of A. oryzae NSAR1 was conducted via the protoplast−polyethylene glycol method. Mycelia of the parent strain from the solid culture in potato dextrose agar were inoculated in 10 mL DPY medium and cultured at 28 °C and 220 rpm for 2 days, which were then transferred to 100 mL DPY medium and cultured for 24 h. The mycelia were collected by filtration and digested by 1% Yatalase in 0.6 M (NH4)2SO4, 50mM maleic acid, pH 5.5 at 30 °C for 4 h to remove cell walls. The resulting protoplasts were collected by centrifugation at 1500 rpm for 10 min and washed once with Solution 2 (1.2 M sorbitol, 50 mM CaCl2.2H2O, 35 mM NaCl, 10M Tris-HCl, pH 7.5). Then, 200 μL protoplast suspension (1 × 107 cells/mL) and about 10 μg plasmids were gently mixed and incubated on ice for 30 min, followed by the addition of 1.3 mL Solution 3 (60% PEG4000, 50 mM CaCl2.2H2O, 10 M Tris-HCl, pH 7.5) at three times. After the mixture was placed at room temperature for 20 min, 5 mL Solution 2 was added. Following centrifugation at 1500 rpm for 10 min, the precipitates were suspended in 200 μL of Solution 2 and spread on the bottom selective medium with 0.8% agar, which was then covered with the selective overlay medium containing 1.5% agar. The selective medium was composed of 0.2% NH4Cl, 0.1% (NH4)2SO4, 0.05% KCl, 0.05% NaCl, 0.1% KH2PO4, 0.05% MgSO4.7H2O, 0.002% FeSO4.7H2O, 2% glucose, 1.2 M sorbitol supplemented with 0.15% methionine, 0.1% arginine, 0.01% adenine, 0.1 μg/mL pyrithiamine hydrobromide and 35 μL/mL glufosinate-ammonium based on the plasmids used. The A. oryzae strain containing the amp cluster was verified by checking the relevant exogenous target genes using PCR analysis (Figure S10). A. oryzae transformants constructed in this study are listed in Table S3.

3.5. Extraction, Isolation, and Characterization

The strain expressing the AO-ampBC construct was cultured in a CD-starch medium (3.0 L) at 28 °C and 220 rpm for 5 days. The culture was extracted with ethyl acetate (3 × 3.0 L). The crude extract was subjected to silica column chromatography eluted with CH2Cl2-methanol (v/v, 100:10). The fraction was purified by RP-HPLC using 55% methanol in water, a flow rate of 3 mL/min, a Welch Ultimate® XB-C18 column (10 mm × 250 mm, 5 μm, Welch) to afford three white solids 1 (10 mg), 2 (15 mg), and 3 (14 mg).

3.6. Anti-Inflammatory Activity

The RAW264.7 cells were used to evaluate the anti-inflammatory activity of compounds 13 following a literature procedure [36]. The cells were seeded in 96-well plates at a density of 5 × 105 cells/mL. After 12 h, LPS (1 µg/mL) and samples were added to the cells and then incubated for 24 h at 37 °C. The quantity of nitrite accumulated in the culture medium was measured as an indicator of NO production. Then, 50 µL of cell culture medium with 100 µL Griess reagent were mixed and incubated for 10 min at room temperature. The absorbance was determined at 540 nm wavelength with a microplate reader.

3.7. Quantification of the Expression of iNOS, COX-2, TNF-α, IL-6, and IL-1β and GAPDH

The RAW264.7 cells were precultured in 6-well plates at a density of 1.0 × 106 cells/mL for 12 h. The cells were then treated with LPS (1 µg/mL), indomethacin (50 µM) together with LPS (1 µg/mL), three concentrations (6.25, 12.5, 25 µM) of amphichopyrone B (2) together with LPS (1 µg/mL) for 24 h at 37 °C under a 5% CO2 atmosphere. The negative control (untread group) was treated only with 0.2% DMSO. The total RNA was isolated using the RNeasy kit (TransGen Biotech Co., Ltd., Beijing, China). The FastKing gDNA Dispelling RT SuperMix (TransGen Biotech Co., Ltd., Beijing, China) was used for reverse transcription at 42 °C for 15 min and 95 °C for 3 min. The BIO-RAD CFX96 Real-Time system (Bio-Rad Laboratories, Inc., Hong Kong, China) and SYBR Green Premix Pro Taq HS qPCR kit (Accurate Biology Co., Ltd., Changsha, China) were used for qPCR amplification of iNOS, COX-2, TNF-α, IL-6, and IL-1β and GAPDH (40 cycles at 95 °C for 5 s and 60 °C for 30 s).

4. Conclusions

Many genome mining strategies have been reported for activating silent BGCs to produce novel natural products. In this study, we heterologously expressed a cryptic gene cluster from Amphichorda felina SYSU-MS7908 in A. oryzae NSAR1 and two new metabolites, amphichopyrone A (1) and amphichopyrone B (2), along with a known compound, udagawanone A (3), were isolated. Amphichopyrone A (1) and amphichopyrone B (2) show potent anti-inflammatory activity by inhibiting LPS-induced NO production with IC50 values 18.09 ± 4.83 and 7.18 ± 0.93 μM, respectively.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/md20050294/s1, Table S1: Primers used in this study; Table S2: Plasmids constructed in this study; Table S3: A. oryzae transformants constructed in this study; Table S4: 1H NMR and 13C NMR data of; Figure S1: The antiSMASH (fungal version) result of Amphichorda felina SYSU-MS7908; Figure S2: The UV spectrum of Amphichopyrone A (1); Figure S3: The UV spectrum of Amphichopyrone B (2); Figure S4: The UV spectrum of undagawanone A (3); Figure S5: The IR spectrum of Amphichopyrone A (1); Figure S6: The IR spectrum of Amphichopyrone B (2); Figure S7: HRESIMS spectrum for Amphichopyrone A (1); Figure S8: HRESIMS spectrum for Amphichopyrone B (2); Figure S9: PCR analysis for the AO-ampABCDEFGHIJ construct.; Figure S10: Amino acid sequence alignment of AmpB with Sol1; NMR Spectra.

Author Contributions

Z.G. and L.L. designed the experiments; S.Y., L.C., Q.W., M.J. and Z.H. performed the experiments; S.C. and H.G. analyzed the data; S.Y. and Z.G. wrote the paper. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by Key-Area Research and Development Program of Guangdong Province (2020B1111030005), National Natural Science Foundation of Guangdong (No. 2018A030313334 and 2019A1515011710), Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai) (No. SML2021SP319), the National Natural Science Foundation of China (Grant Nos. U20A2001), and the Open Fund of State Key Laboratory of Applied Optics (SKLAO2020001A10).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We thank Ikuro Abe and Katsuhiko Kitamoto for the quadruple auxotrophic heterologous expression host Aspergillus oryzae NSAR1.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Pham, J.V.; Yilma, M.A.; Feliz, A.; Majid, M.T.; Maffetone, N.; Walker, J.R.; Kim, E.; Cho, H.J.; Reynolds, J.M.; Song, M.C.; et al. A review of the microbial production of bioactive natural products and biologics. Front. Microbiol. 2019, 10, 1404. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Woodruff, H.B. Natural products from microorganisms. Science 1980, 208, 1225–1229. [Google Scholar] [CrossRef] [PubMed]
  3. Rutledge, P.J.; Challis, G.L. Discovery of microbial natural products by activation of silent biosynthetic gene clusters. Nat. Rev. Microbiol. 2015, 13, 509–523. [Google Scholar] [CrossRef] [PubMed]
  4. Zhu, Y.; Wang, J.; Mou, P.; Yan, Y.; Chen, M.; Tang, Y. Genome mining of cryptic tetronate natural products from a PKS-NRPS encoding gene cluster in Trichoderma harzianum t-22. Org. Biomol. Chem. 2021, 19, 1985–1990. [Google Scholar] [CrossRef] [PubMed]
  5. Li, H.; Shu, S.; Kalaitzis, J.A.; Shang, Z.; Vuong, D.; Crombie, A.; Lacey, E.; Piggott, A.M.; Chooi, Y.H. Genome mining of Aspergillus hancockii unearths cryptic polyketide hancockinone A featuring a prenylated 6/6/6/5 carbocyclic skeleton. Org. Lett. 2021, 23, 8789–8793. [Google Scholar] [CrossRef]
  6. Jiang, L.; Zhang, X.; Sato, Y.; Zhu, G.; Minami, A.; Zhang, W.; Ozaki, T.; Zhu, B.; Wang, Z.; Wang, X.; et al. Genome-based discovery of enantiomeric pentacyclic sesterterpenes catalyzed by fungal bifunctional terpene synthases. Org. Lett. 2021, 23, 4645–4650. [Google Scholar] [CrossRef]
  7. Yan, D.; Matsuda, Y. Genome mining-driven discovery of 5-methylorsellinate-derived meroterpenoids from Aspergillus funiculosus. Org. Lett. 2021, 23, 3211–3215. [Google Scholar] [CrossRef]
  8. Chen, S.; Jiang, M.; Chen, B.; Salaenoi, J.; Niaz, S.-I.; He, J.; Liu, L. Penicamide A, a unique N,N′-ketal quinazolinone alkaloid from ascidian-derived fungus Penicillium sp. 4829. Mar. Drugs 2019, 17, 522. [Google Scholar] [CrossRef] [Green Version]
  9. Chen, S.; Shen, H.; Deng, Y.; Guo, H.; Jiang, M.; Wu, Z.; Yin, H.; Liu, L. Roussoelins A and B: Two phenols with antioxidant capacity from ascidian-derived fungus Roussoella siamensis SYSU-MS4723. Mar. Life Sci. Technol. 2021, 3, 69–76. [Google Scholar] [CrossRef]
  10. Chen, S.; Shen, H.; Zhang, P.; Cheng, H.; Dai, X.; Liu, L. Anti-glioma trichobamide A with an unprecedented tetrahydro-5H-furo[2,3-b]pyrrol-5-one functionality from ascidian-derived fungus Trichobotrys effuse 4729. Chem. Commun. 2019, 55, 1438–1441. [Google Scholar] [CrossRef]
  11. Niaz, S.-I.; Zhang, P.; Shen, H.; Li, J.; Chen, B.; Chen, S.; Liu, L.; He, J. Two new isochromane derivatives penisochromanes A and B from ascidian-derived fungus Penicillium sp. 4829. Nat. Prod. Res. 2019, 33, 1262–1268. [Google Scholar] [CrossRef] [PubMed]
  12. Jiang, M.H.; Wu, Z.E.; Wu, Q.L.; Yin, H.M.; Guo, H.; Yuan, S.W.; Liu, Z.M.; Chen, S.H.; Liu, L. Amphichoterpenoids A-C, unprecedented picoline-derived meroterpenoids from the ascidian-derived fungus Amphichorda felina SYSU-MS7908. Chin. Chem. Lett. 2021, 32, 1893–1896. [Google Scholar] [CrossRef]
  13. Liang, M.; Lyu, H.N.; Ma, Z.Y.; Li, E.W.; Cai, L.; Yin, W.B. Genomics-driven discovery of a new cyclodepsipeptide from the guanophilic fungus Amphichorda guana. Org. Biomol. Chem. 2021, 19, 1960–1964. [Google Scholar] [CrossRef] [PubMed]
  14. Weber, T.; Blin, K.; Duddela, S.; Krug, D.; Kim, H.U.; Bruccoleri, R.; Lee, S.Y.; Fischbach, M.A.; Müller, R.; Wohlleben, W.; et al. antiSMASH 3.0—a comprehensive resource for the genome mining of biosynthetic gene clusters. Nucleic Acids Res. 2015, 43, W237–W243. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Lee, J. Recent Advances in the synthesis of 2-pyrones. Mar. Drugs 2015, 13, 1581–1620. [Google Scholar] [CrossRef] [Green Version]
  16. McGlacken, G.P.; Fairlamb, I.J. 2-Pyrone natural products and mimetics: Isolation, characterisation and biological activity. Nat. Prod. Rep. 2005, 22, 369–385. [Google Scholar] [CrossRef]
  17. Macabeo, A.P.G.; Cruz, A.J.C.; Narmani, A.; Arzanlou, M.; Babai-Ahari, A.; Pilapil, L.A.E.; Garcia, K.Y.M.; Huch, V.; Stadler, M. Tetrasubstituted α-pyrone derivatives from the endophytic fungus, Neurospora udagawae. Phytochem. Lett. 2020, 35, 147–151. [Google Scholar] [CrossRef]
  18. Kasahara, K.; Miyamoto, T.; Fujimoto, T.; Oguri, H.; Tokiwano, T.; Oikawa, H.; Ebizuka, Y.; Fujii, I. Solanapyrone synthase, a possible Diels-Alderase and iterative type I polyketide synthase encoded in a biosynthetic gene cluster from Alternaria solani. ChemBioChem 2010, 11, 1245–1252. [Google Scholar] [CrossRef]
  19. Zhang, W.Y.; Zhong, Y.; Yu, Y.; Shi, D.F.; Huang, H.Y.; Tang, X.L.; Wang, Y.H.; Chen, G.D.; Zhang, H.P.; Liu, C.L.; et al. 4-Hydroxy pyridones from heterologous expression and cultivation of the native host. J. Nat. Prod. 2020, 83, 3338–3346. [Google Scholar] [CrossRef]
  20. Guo, J.; Cai, Y.S.; Cheng, F.; Yang, C.; Zhang, W.; Yu, W.; Yan, J.; Deng, Z.; Hong, K. Genome mining reveals a multiproduct sesterterpenoid biosynthetic gene cluster in Aspergillus ustus. Org. Lett. 2021, 23, 1525–1529. [Google Scholar] [CrossRef]
  21. Wang, W.-G.; Du, L.-Q.; Sheng, S.-L.; Li, A.; Li, Y.-P.; Cheng, G.-G.; Li, G.-P.; Sun, G.; Hu, Q.-F.; Matsuda, Y. Genome mining for fungal polyketide-diterpenoid hybrids: Discovery of key terpene cyclases and multifunctional P450s for structural diversification. Org. Chem. Front. 2019, 6, 571–578. [Google Scholar] [CrossRef]
  22. Gilchrist, C.L.M.; Chooi, Y.H. Clinker & clustermap.js: Automatic generation of gene cluster comparison figures. Bioinformatics 2021, 37, 2473–2475. [Google Scholar]
  23. Kim, W.; Park, J.-J.; Gang, D.R.; Peever, T.L.; Chen, W. A novel type pathway-specific regulator and dynamic genome environments of a solanapyrone biosynthesis gene cluster in the fungus Ascochyta rabiei. Eukaryot. Eukaryot. Cell 2015, 14, 1102–1113. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Kim, W.; Park, C.-M.; Park, J.-J.; Akamatsu, H.O.; Peever, T.L.; Xian, M.; Gang, D.R.; Vandemark, G.; Chen, W. Functional analyses of the Diels-Alderase gene sol5 of Ascochyta rabiei and Alternaria solani indicate that the solanapyrone phytotoxins are not required for pathogenicity. Mol. Plant-Microbe Interact. 2015, 28, 482–496. [Google Scholar] [CrossRef] [Green Version]
  25. Fujimoto, H.; Satoh, Y.; Yamazaki, M. Four new immunosuppressive components, Kobiin and Kobifuranones A, B, and C, from an Ascomycete, Gelasinospora kobi. Chem. Pharm. Bull. 1998, 46, 211–216. [Google Scholar] [CrossRef] [Green Version]
  26. Fujimoto, H. Immunomodulatory constituents from Ascomycetous fungi. J. Nat. Med. 2018, 72, 20–31. [Google Scholar] [CrossRef]
  27. Sun, L.D.; Wang, F.; Dai, F.; Wang, Y.H.; Lin, D.; Zhou, B. Development and mechanism investigation of a new piperlongumine derivative as a potent anti-inflammatory agent. Biochem. Pharmacol. 2015, 95, 156–169. [Google Scholar] [CrossRef]
  28. Xue, G.M.; Li, X.Q.; Chen, C.; Chen, K.; Wang, X.B.; Gu, Y.C.; Luo, J.G.; Kong, L.Y. Highly oxidized guaianolide sesquiterpenoids with potential anti-inflammatory activity from Chrysanthemum indicum. J. Nat. Prod. 2018, 81, 378–386. [Google Scholar] [CrossRef]
  29. Kjer, J.; Debbab, A.; Aly, A.H.; Proksch, P. Methods for isolation of marine-derived endophytic fungi and their bioactive secondary products. Nat. Protoc. 2010, 5, 479–490. [Google Scholar] [CrossRef]
  30. Jin, F.J.; Maruyama, J.; Juvvadi, P.R.; Arioka, M.; Kitamoto, K. Development of a novel quadruple auxotrophic host transformation system by argB gene disruption using adeA gene and exploiting adenine auxotrophy in Aspergillus oryzae. FEMS Microbiol. Lett. 2004, 239, 79–85. [Google Scholar] [CrossRef] [Green Version]
  31. Fujii, T.; Yamaoka, H.; Gomi, K.; Kitamoto, K.; Kumaga, C. Cloning and nucleotide sequence of the ribonuclease T1 gene (rntA) from Aspergillus oryzae and its expression in Saccharomyces cerevisiae and Aspergillus oryzae. Biosci. Biotechnol. Biochem. 1995, 59, 1869–1874. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Kubodera, T.; Yamashita, N.; Nishimura, A. Pyrithiamine resistance gene (ptrA) of Aspergillus oryzae: Cloning, characterization and application as a dominant selectable marker for transformation. Biosci. Biotechnol. Biochem. 2000, 64, 1416–1421. [Google Scholar] [CrossRef] [PubMed]
  33. Pall, M.L.; Brunelli, J.P. A series of six compact fungal transformation vectors containing polylinkers with multiple unique restriction sites. Fungal Genet. Newsl. 1993, 40, 59–62. [Google Scholar] [CrossRef] [Green Version]
  34. Jin, F.J.; Maruyama, J.-I.; Juvvadi, P.R.; Arioka, M.; Kitamoto, K. Adenine auxotrophic mutants of Aspergillus oryzae: Development of a novel transformation system with triple auxotrophic hosts. Biosci. Biotechnol. Biochem. 2004, 68, 656–662. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Yamada, O.; Lee, B.R.; Gomi, K.; Iimura, Y. Cloning and functional analysis of the Aspergillus oryzae conidiation regulator gene brlA by its disruption and misscheduled expression. J. Biosci. Bioeng. 1999, 87, 424–429. [Google Scholar] [CrossRef]
  36. Li, H.; Zhang, Q.; Jin, X.; Zou, X.; Wang, Y.; Hao, D.; Fu, F.; Jiao, W.; Zhang, C.; Lin, H.; et al. Dysifragilone A inhibits LPS induced RAW264.7 macrophage activation by blocking the p38 MAPK signaling pathway. Mol. Med. Rep. 2018, 17, 674–682. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Representative natural products containing α-pyrone motif.
Figure 1. Representative natural products containing α-pyrone motif.
Marinedrugs 20 00294 g001
Figure 2. Comparison of the amp cluster with the sol cluster was performed using the Clinker tool [22].
Figure 2. Comparison of the amp cluster with the sol cluster was performed using the Clinker tool [22].
Marinedrugs 20 00294 g002
Figure 3. HPLC profiles obtained after expression of respective constructs in A. oryzae.
Figure 3. HPLC profiles obtained after expression of respective constructs in A. oryzae.
Marinedrugs 20 00294 g003
Figure 4. Chemical structures of 13.
Figure 4. Chemical structures of 13.
Marinedrugs 20 00294 g004
Figure 5. The biosynthetic pathway of 13. AmpB is responsible for the formation of amphichopyrone A (1); AmpC introduces a methyl group to give amphichopyrone B (2) by AmpC; hydroxylation of amphichopyrone B (2) to udagawanone A (3) might be catalysed by endogenous enzymes from A. oryzae NSAR1 host.
Figure 5. The biosynthetic pathway of 13. AmpB is responsible for the formation of amphichopyrone A (1); AmpC introduces a methyl group to give amphichopyrone B (2) by AmpC; hydroxylation of amphichopyrone B (2) to udagawanone A (3) might be catalysed by endogenous enzymes from A. oryzae NSAR1 host.
Marinedrugs 20 00294 g005
Figure 6. The key HMBC (red arrow) correlations of compounds 1 and 2.
Figure 6. The key HMBC (red arrow) correlations of compounds 1 and 2.
Marinedrugs 20 00294 g006
Figure 7. The effect of amphichopyrone B (2) on the LPS-induced iNOS, COX-2, TNF-α, IL-6, and IL-1β expression. The ‘untreated’ bar is cells only treated with 0.2% DMSO, the ‘LPS’ bar is cells treated with LPS (1 µg/mL) with 0.2% DMSO, the ‘INDO’ bar is cells treated with indomethacin (50 µM) together and LPS (1 µg/mL), and 25 µM\12.5 µM\6.25 µM represents cells treated with three concentrations of amphichopyrone B (2) together with LPS (1 µg/mL). The mRNA expression levels of iNOS, COX-2, TNF-α, IL-6, and IL-1β were down-regulated, suggesting that the LPS-induced inflammatory processes were inhibited by amphichopyrone B. * p < 0.05 vs. LPS treatment group.
Figure 7. The effect of amphichopyrone B (2) on the LPS-induced iNOS, COX-2, TNF-α, IL-6, and IL-1β expression. The ‘untreated’ bar is cells only treated with 0.2% DMSO, the ‘LPS’ bar is cells treated with LPS (1 µg/mL) with 0.2% DMSO, the ‘INDO’ bar is cells treated with indomethacin (50 µM) together and LPS (1 µg/mL), and 25 µM\12.5 µM\6.25 µM represents cells treated with three concentrations of amphichopyrone B (2) together with LPS (1 µg/mL). The mRNA expression levels of iNOS, COX-2, TNF-α, IL-6, and IL-1β were down-regulated, suggesting that the LPS-induced inflammatory processes were inhibited by amphichopyrone B. * p < 0.05 vs. LPS treatment group.
Marinedrugs 20 00294 g007
Table 1. Proposed functions of open reading frames in the amp cluster.
Table 1. Proposed functions of open reading frames in the amp cluster.
AmpAAHomolog (Accession No.)S/I a (%)Proposed Function
A285--Methyltransferase
B2633Sol1 (D7UQ44.1)67.5/51.0polyketide synthase
C455Sol2 (XP_045265976.1)64.6/49.5O-methyltransferase
D5831A4 (CRG92717.1)85.6/72.9p450
E273DltE (XP_045265975.1)86.4/72.5Oxidoreductase
F518ChyH (XP_037172406.1)80.6/67.4FAD-linked oxidoreductase
G487p450
H422Unknown
I398Unknown
J253CsgA (CZT51343.1)70.8/52.2short-chain dehydrogenase/reductase
a Similarity/identity, AA: Amino acid.
Table 2. 1H (400 MHz) and 13C (100 MHz) NMR data of 1 and 2 in acetone-d6.
Table 2. 1H (400 MHz) and 13C (100 MHz) NMR data of 1 and 2 in acetone-d6.
No12
δH,(J in Hz)δC, TypeδH,(J in Hz)δC, Type
2 163.6, C 164.5, C
3 99.0, C 111.2, C
4 164.3, C 168.7, C
5 106.3, C 109.4, C
6 151.6, C 153.0, C
76.42, dq (15.4, 1.3)120.6, CH6.42, dq (15.4, 1.3)121.4, CH
86.50, dq (15.4, 6.0)132.0, CH6.51, dq (15.4, 6.5)133.1, CH
91.90, d (6.0)17.6, CH31.91, d (6.5)18.6, CH3
101.94, s8.6, CH31.96, s10.4, CH3
112.01, s8.4, CH31.98, s9.5, CH3
12 3.83, s60.7, CH3
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Yuan, S.; Chen, L.; Wu, Q.; Jiang, M.; Guo, H.; Hu, Z.; Chen, S.; Liu, L.; Gao, Z. Genome Mining of α-Pyrone Natural Products from Ascidian-Derived Fungus Amphichordafelina SYSU-MS7908. Mar. Drugs 2022, 20, 294. https://doi.org/10.3390/md20050294

AMA Style

Yuan S, Chen L, Wu Q, Jiang M, Guo H, Hu Z, Chen S, Liu L, Gao Z. Genome Mining of α-Pyrone Natural Products from Ascidian-Derived Fungus Amphichordafelina SYSU-MS7908. Marine Drugs. 2022; 20(5):294. https://doi.org/10.3390/md20050294

Chicago/Turabian Style

Yuan, Siwen, Litong Chen, Qilin Wu, Minghua Jiang, Heng Guo, Zhibo Hu, Senhua Chen, Lan Liu, and Zhizeng Gao. 2022. "Genome Mining of α-Pyrone Natural Products from Ascidian-Derived Fungus Amphichordafelina SYSU-MS7908" Marine Drugs 20, no. 5: 294. https://doi.org/10.3390/md20050294

APA Style

Yuan, S., Chen, L., Wu, Q., Jiang, M., Guo, H., Hu, Z., Chen, S., Liu, L., & Gao, Z. (2022). Genome Mining of α-Pyrone Natural Products from Ascidian-Derived Fungus Amphichordafelina SYSU-MS7908. Marine Drugs, 20(5), 294. https://doi.org/10.3390/md20050294

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop